NUVECTIS PHARMA INC (NVCT): Institutional Ownership
Hedge funds and institutional managers reporting a position in NVCT · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
5
13F filers
Aggregate Value
$556K
Across holders
Last Price
$27.19
2026-06-26
Sector
Health Care
GICS
Holder activity2 new1 added2 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 | Hedge Fund | 43K | $258K | 46.4% | 0.0% | Reduced | $-1K | Q3 2025 |
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 13K | $132K | 23.7% | 0.0% | New | — | Q1 2025 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 18K | $111K | 20.0% | 0.0% | Added | +$2K | Q3 2025 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 5K | $39K | 7.1% | 0.0% | New | — | Q1 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 2K | $16K | 2.9% | 0.0% | Reduced | $-96K | Q1 2026 |
Reduced
Hedge Fund
$258K· 46.4% of total· 0.0% port· 43K sh· $-1K QoQ· Q3 2025
New
Hedge Fund
$132K· 23.7% of total· 0.0% port· 13K sh· — QoQ· Q1 2025
Added
Hedge Fund
$111K· 20.0% of total· 0.0% port· 18K sh· +$2K QoQ· Q3 2025
New
Hedge Fund
$39K· 7.1% of total· 0.0% port· 5K sh· — QoQ· Q1 2026
Reduced
Hedge Fund
$16K· 2.9% of total· 0.0% port· 2K sh· $-96K QoQ· Q1 2026